Projects per year
Personal profile
Further information
Branches of science
- 106 Biology
- 301 Medical-Theoretical Sciences, Pharmacy
Fingerprint
Dive into the research topics where Stefano Angiari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Immunometabolic biomarkers and therapeutic targets in multiple sclerosis
Angiari, S. (Principal investigator)
1/10/24 → 31/12/27
Project: Research funding
-
Evaluating the role of succinate sensing via GPR91 in T cell-mediated anti-tumour immunity
Angiari, S. (Principal investigator)
1/03/23 → 30/09/26
Project: Research funding
-
T cell metabolism in CTD-ILD: Metabolic signatures of T cell subsets as novel diagnostic or therapeutic targets in connective tissue disease-associated interstitial lung disease
Rittchen, S. (Principal investigator), Angiari, S. (Co-principal investigator) & Fessler, J. (Co-principal investigator)
1/01/24 → 31/12/25
Project: Research funding
-
Pyruvate kinase isoforms as novel biomarkers and therapeutic targets in multiple sclerosis
Angiari, S. (Principal investigator) & Khalil, M. (Co-investigator)
1/05/23 → 30/04/24
Project: Research funding
-
Ein neuartiger potenzieller immunometabolischer Ansatz für die Behandlung von Neuroinflammation: die Ausrichtung auf Pyruvatkinase M2 in CD4+ T-Zellen bei Multipler Sklerose.
Angiari, S. (Principal investigator) & Khalil, M. (Co-investigator)
1/04/22 → 30/09/23
Project: Research funding
-
A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogramming
Mori, E., Santis, E. D., Scalera, M., Meissel, J., Ellmeier, E., Flori, A., Menichetti, L., Schmidt, G., Cattaneo, A., Angiari, S., Costa, M. & Vannini, E., 30 May 2026, In: Journal of Translational Medicine. 24, 1Research output: Contribution to journal › Research article
-
Investigation and correction of size-dependent transport efficiencies of microparticles in SP ICP-MS analysis
Elinkmann, M., Kronenberg, K., Ellmeier, E., Schwarzenberger, E., Paton, L., de Vega, R. G., Angiari, S. & Clases, D., 1 Oct 2026, In: Talanta. 308, p. 129835 8 p., 129835.Research output: Contribution to journal › Research article
3 Citations (Web of Science) -
Spatial transcriptomics reveals compartment-specific cytotoxic T cell crosstalk with AT2 and goblet cells in advanced COPD
Syarif, A. H. (First author), Reiter, B. F. E., Avian, A., Milger, K., Ellmeier, E., Hoefler, G., Aigner, C., Benazzo, A., Auner, S., Crnkovic, S., Angiari, S., Polverino, F., Kwapiszewska, G. & Marsh, L. M., 25 Jun 2026, (E-pub ahead of print) In: Biomarker Research.Research output: Contribution to journal › Research article
-
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis.
Ellmeier, E. (First author), Schnabl, A., Meissel, J., Stracke, A., Rittchen, S., Passegger, C., Tafrali, C., Demjaha, R., Martinez Serrat, M., Kaiser, T., Zeiler, L., Seifried, K., Topler, A., Heschl, B., Damulina, A., Runtsch, M., Fessler, J., Hofer, E., Khalil, M. & Angiari, S., Jun 2026, In: eBioMedicine. 128, p. 106314 21 p., 106314.Research output: Contribution to journal › Research article
-
Adenosine 2A receptor-dependent activation of AMPK represses TH17 cell pathogenicity through epigenetic and metabolic reprogramming.
Papadopoulou, G., Valakos, D., Polydouri, I., Moulara, A., Vatsellas, G., Angiari, S., Runtsch, M., Foretz, M., Viollet, B., Cassotta, A., O'Neill, L. & Xanthou, G., 23 Sept 2025, In: Science Signaling. 18, 905, p. eadr3177 17 p., eadr3177.Research output: Contribution to journal › Research article
-
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
Angiari, S. (Speaker)
12 Jun 2026Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
CTX-CNF1 BOOSTS GLIOBLASTOMA SURVIVAL BY REPROGRAMMING THE IMMUNE MICROENVIRONMENT
Mori, E. (Author), De Santis, E. (Author), Scalera, M. (Author), Meissel, J. (Author), Ellmeier, E. (Author), Flori, A. (Author), Menichetti, L. (Author), Schmidt, G. (Author), Cattaneo, A. (Author), Angiari, S. (Author), Costa, M. (Author) & Vannini, E. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Biomedicine and Pharmacotherapy (Journal)
Angiari, S. (Reviewer)
2025Activity: Peer-review and editorial work › Peer-review activitiy
-
Novel immunometabolic targets to modulate human T cell-mediated inflammation
Angiari, S. (Author)
2025Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis.
Angiari, S. (Author) & Seifried, K. (Author)
2024Activity: Talk, presentation or poster › Poster